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Aim: To examine whether subjective wellbeing (SW) and body concern among adolescents 
aged 15-19 years has an impact on adult health, measured by medications dispensed on 
average 18 years later. 
Methods: Data collected in the Nord-Trøndelag Health Study (HUNT) was paired with data 
from the Norwegian Prescription database (NorPD). We investigated the effects of adolescent 
SW and body concern on total number of medications, on use of antiinfectives (ATC-group 
J), medication for the musculo-skeletal system (ATC-group M), anxiolytics, hypnotics and 
sedatives (ATC-groups N05B and N05C), and finally antipsychotics, antidepressants and 
psychostimulants, agents used for adhd and nootropics (ATC-groups N05A, N06A and 
N06B).  We used multi-variable models where we entered body dissatisfaction and SW 
simultaneously in the models in order to adjust for the associations between the predictors, 
and also adjusted for possible confounders in the models. 
Results: Both body concern (dieting and dieting desire) and impaired SW predicted drug use 
17-18 years after the participants were surveyed in adolescence. The impact was disease 
specific as body concern was the most influential predictor for drugs used for somatic 
diseases and complaints, whereas impaired SW was more strongly associated with drug use 
for mental health diseases and complaints 
Conclusions: SW and body concern are important health determinants in the transition 
between adolescence and adulthood. 
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In health care today, medicines are one of the main interventions used to treat and prevent 
diseases, and to relieve disease symptoms.  More than 50% of medical encounters will lead to 
prescription of one or more drugs1. In Norway, the percentage of the population that has 
collected a prescribed drug from the pharmacy has risen from 67.3 % in 2005, to 69.8% in 
20172. We consider prescription an objective health indicator, as the prescription is done 
when physician considers that a disease or an illness episode needs medical treatment. 
 The Norwegian prescription data base provides information on all prescriptions 
dispensed by Norwegian pharmacies. While it can only give information on which medication 
has been collected by the patient, not what has been actually ingested, it is a reliable source of 
intended medication use. Data from the prescription data base can therefore function as a 
valid and objective health outcome measurement as compared with self-reports that are prone 
to recall and affectivity bias3. 
Subjective well-being (SW) pertains to happiness and satisfaction with life, both in the 
present and in the future4. The cognitive dimension deals with satisfaction with life, while the 
affective dimensions deal with positive and negative affect. Affect can be referred to as 
emotional reactions to events that happen in life5.  
We discern several theories of how SW is influenced6, 7. «Bottom up theories» 
maintain that it is the influence of life-events that decides a person’s SW, while “Top down 
theories” maintain that SW is the result of how the person evaluates life events, so that SW is 
more a result of personality than life events6. A «Dynamic Equilibrium Model», maintains 
that SW, life events and personality are factors in a circular and reciprocal dynamic 
equilibrium. Within the “positive psychology” tradition, factors like life gratitude and 
personal relations are important for SW8.  
Sociodemographic factors like sex, age and socioeconomic status (SES) impact SW 
during adolescence only to a limited degree9. However, body concern and dissatisfaction 
influence SW strongly, and especially the affective component10. The health consequences of 
body concern have mostly been studied among females, and often among groups with eating 
disorders. Therefore, we may question if these findings are transferable to the general 
population11. An epidemiologic study of a general population of adolescents found that body 
concern was associated prospectively with depression 5 years later in boys as well as in 
girls12. How SW impacts later health and longevity is unclear. It is mostly studied in middle-
aged populations and seems to be disease specific13. 
On this background we set out to examine whether SW and body concern among 
adolescents aged 15-19 years impact adult health, measured by medications dispensed on 
average 18 years later. We examined medications from a range of therapeutic classes (ATC-
codes) in order to discern if the impact was disease specific. We used multi-variable models 
where we entered body dissatisfaction and SW simultaneously in the models in order to adjust 
for the associations between the predictors, and also adjusted for possible confounders in the 
models. 
Material and methods 
In this study, we used data collected in the Nord-Trøndelag Health Study (HUNT), paired 
with data from the Norwegian Prescription database (NorPD).  
In 1995-1997, all students in secondary school or high school in the county of Nord-
Trøndelag were invited to participate in the Young-HUNT-survey. Young-HUNT is a part of 
the larger Nord-Trøndelag Health Study (HUNT), which compasses all inhabitants in the 
county of Nord-Trøndelag who are 13 years old or older. A total of 8982 persons agreed to 
participate (90 % response rate), of which 4463 were girls (49. 7%). Participants' age ranged 
from 12 – 21, mean age was 16 years old. The questionnaire was filled in during school hours, 
and the students placed it in an envelope and sealed it. All responses were tied to the students’ 
unique personal identification number, making it possible to link them to data in the NorPD, 
via the Norwegian Institute of Public Health. For a description of the linkage procedure see: 
https://www.ntnu.edu/hunt/merging-registries.  
The main themes of the Young-HUNT questionnaire were asthma and allergies, 
subjective health complaints, eating disorders, and psychosomatic disorders with special 
attention to headache and mental health. Anxiety, depression, self-esteem, and well-being 
were included within mental health. In addition, information was collected on use of 
medications, indoor climate exposure, tobacco and alcohol use, physical activity, their use of 
health services, stages of puberty, and reading and writing difficulties.  
Students in high school (16-19 years old) were given an extra page of questions, 
otherwise the questions were the same as those given to students in secondary school (13-15 
years old).  
NorPD2 is a complete register of all prescription medication that has been dispensed 
from Norwegian community and hospital pharmacies to non-institutionalized individuals 
from 2004 and onward. Here we use data from the years 2013 and 2014 for all participants in 
the Young-HUNT study.  
 
Subjective wellbeing and body concern 
The measurement of subjective wellbeing was based on a shorter version of a wellbeing scale 
that has been found to have good psychometric properties14. It comprises four questions (see 
Table 1), related to both the cognitive and affective aspects of subjective well-being. 
Responses were given on a scale from 1-7. The response alternatives were adjusted so a 
higher value corresponds to a lower subjective well-being. The variable was therefore named 
“lack of subjective well-being”. The last question, “Have you been bothered by nervousness 
during the last month?”, had only 4 response alternatives. This was transformed to a 1-7 scale 
in analysis. The sum-variable was excluded from analysis if the participants had answered 
less than two of the questions it contained.   
Body concern was measured using a single question: “Are you currently trying to lose 
weight?”, with the response alternatives: "Yes", "No, but I need to lose weight", and "No, my 
weight is ok" (Table 1). 
Medication use at inclusion 
“Medication use at inclusion” was included as an adjustment variable. The participants were 
asked whether they used medication from the following groups: pain treatment, migraine 
treatment, sleeping medication, nerve medicine, anti-anxiety medication, asthma medication, 
allergy medication and/or antiepileptic medication. They were asked how often each 
medication was used: “never”, “sometimes” or “almost every day”, with the corresponding 
scores of 1, 2 and 3, respectively. If one of these questions was left unanswered, it was given 
the score of 1, assuming that the drug was not used. A sum-score of the values, subtracted 
eight, was used as a measure of the youths’ health at the time of the survey, giving a scale 
ranging from 0 to 14. The "medication use at inclusion" variable does not represent the true 
number of medications used, but rather gives an indication of the persons’ “medication load”, 
based both on use of different drug groups in question and frequency of use. 
Medication use in adult life 
The dependent variables were use of different medication in adult age. All medication in the 
NorPD is classified according to the Anatomical Therapeutic Chemical (ATC) classification 
system. In addition to total number of medications (excluding hormonal contraceptives), we 
investigated four groups of medication: antiinfectives for systemic use (ATC-group J), 
medication for the musculo-skeletal system (ATC-group M), anxiolytics, hypnotics and 
sedatives (ATC-groups N05B and N05C), and finally antipsychotics, antidepressants and 
psychostimulants, agents used for adhd and nootropics (ATC-groups N05A, N06A and 
N06B).   Use was divided into 3 categories, as seen in Table 2.  
Statistics 
We performed unadjusted ordinal regression using medication use at adult age as dependant 
variable, and the variables sex, age, medication use at inclusion, body concern, and lack of 
subjective wellbeing as independent variables. This was followed by adjusted analysis of 
body concern, and lack of subjective wellbeing, while adjusting for the remaining variables. 
Finally, we performed a complete model analysis, including all variables. Results are given as 
p-values, and OR with accompanying 95 % confidence intervals. A p-value <0.05 was 
accepted as significant. All analysis was done using SPSS, v. 22. We evaluated the models 
using model fitting information, goodness of fit and test of parallel lines. 
Ethics 
All participants, and, for those under 16, their parents or guardians, gave written consent to 
participate in the HUNT study and to use the data for research. Participation was voluntary. 
The study was approved by the Norwegian Data Inspectorate, the Regional and National 




Table 1 shows the number of valid responses to the four wellbeing questions, and how the 
participants responded to the question regarding body concern. Somewhat fewer boys than 
girls reported that they were dissatisfied with their weight: nine percent of boys were trying to 
lose weight, 15.6 % stated they should lose weight and 75.4 % of the boys were satisfied with 
their own weight. The corresponding numbers for girls were 12.6%, 21.2%, and 66.2%. The 
mean score for medication use at inclusion was 0.99 (SD=1.10, range 0-14).  
The total number of collected prescriptions during the years of 2013 and 2014 ranged from 0 
to 587, with a mean of 8.16 (Table 2). The four groups of medication we investigated (N05B 
and N05C, N05A, N06A and N06B, M, and J) constituted 33% of the total number 
prescriptions in our analyses (all prescriptions except the ATC codes related to reproductive 
health). 
From Table 3 we see that impaired SW (OR from full model analysis 1.11, p<0.001) and 
dieting (OR 1.27, p=0.001), as well as the feeling that one should lose weight (OR 1.14, 
p=0.016), all predict total drugs dispensed on average 18 years after the baseline examination. 
The associations are present both in the adjusted analyses and in the full model analysis. 
Table 4 reports the associations of the predictors with later drugs dispensed for 
musculoskeletal diseases and symptoms, and for use of anti-infectives for systemic use. The 
associations between use of musculoskeletal medication and body dissatisfaction are 
statistically significant in both adjusted and full model analyses (OR 1.20, p=0.002, and OR 
1.32, p<0.001 for dieting desire and dieting, respectively). Impaired SW lacks statistically 
significant associations with later musculoskeletal drug use. For anti-infective medication, the 
adjusted analysis showed that impaired SW predicted use of anti-infective drugs (OR 1.05, 
p=0.033), but not in the full model analysis (OR 1.04, p=0.093). Dieting (but not dieting 
desire), influenced later use of anti-infective drugs significantly both in the adjusted (OR 1.25, 
p=0.001) and in the full model analysis (OR 1.23, p=0.004). 
In Table 5 we report the associations between the predictors and dispensed anxiolytics and 
hypnotic drugs, and between predictors and dispensed antipsychotics, antidepressants and 
psychostimulants. Impaired SW predicted drug use in the adjusted as well as in the full model 
analyses for both drug groups. The OR in full model analyses for the prediction from SW on 
dispensed anxiolytic and hypnotic drugs was 1.34 (p<0.001), and 1.47 (p<0.001) on dispensed 
antipsychotics, antidepressants and psychostimulants. However, we see that body 
dissatisfaction predicted drug use only in the adjusted analysis, but not in the full model 
analyses where we adjusted for the inter-relation between the predictors.  
The explained variances for the full model analyses were low, ranging from 0.014 to 0.079. 
Female sex was associated with higher drug use for all of the associations. We did stratified 
analyses for men and women, and found vastly overlapping CIs. Therefore, we chose not to 
report the stratified analyses, but rather use participants’ sex as an adjusting variable. Drug 
use at baseline was strongly associated with later drug use for the total and all the separate 
ATC-codes, documenting the relevance of using this variable as an adjusting variable. Mean 
body mass index had no effect on how the participants replied to the question regarding body 
concern (results not shown). The tests for Model Fitting Information showed that age added 
no significant value to the full model in any of the analyses. If tests for parallel lines were 
significant we performed simple logistic regression analyses and confirmed that odds for both 
cut offs were within the confidence limits for the ordinal analyses. ORs from the ordinal 
regressions were quite similar for both cut-off limits in the analyses, although the ORs for the 
first step were slightly overestimated, and slightly underestimated for the second step. Model 
fitting and tests for parallel lines were satisfactory. Goodness of fit showed significant p-




This study revealed that both body concern (dieting and dieting desire) and impaired SW 
predicted drug use 17-18 years after the participants were surveyed at baseline. The impact 
was disease specific as body concern was the most influential predictor for drugs used for 
somatic diseases and complaints, whereas impaired SW was more strongly associated with 
drug use for mental health diseases and complaints 
How our results relate to other research 
The associations between SW and anxiety and depression are well established also in younger 
age-groups. Negative affect is a common characteristic for both anxiety and depression19. 
Associations between sleeping problems and impaired SW are also confirmed20. In some 
studies SW and positive affect even seem to protect against viral infections21. However, these 
previous studies are all cross sectional, making inference about the causal directions dubious. 
The present study suggests a causal link between impaired SW and later medication use for 
mental illness and complaints. When we adjust for the inter-relationship between SW and 
body concern, the predictive ability of SW on later use of anti-microbial drugs disappears.  
The finding that body dissatisfaction had no predictive ability for mental illness medications 
was surprising. The association between body concern and depression has been well 
established in longitudinal studies12, 22, 23. Former longitudinal studies were, however, of much 
shorter duration, with a maximum of five years. Bodily and emotional complaints among 
adolescents and young adults are closely inter-related24 and medications for musculoskeletal 
complaints might therefore be an expression for mental as well as somatic disease. 
The predictive ability of body concern for use of anti-infectiva is, however, more specific and 
cannot be explained only by comorbidity. One explanation may be that body concern 
represents an exaggerated preoccupation with body and bodily symptoms and deviations, 
leading to more frequent health care attendance and pressure on physicians to prescribe. 
However, it is also possible that body concern represents a chronic stressor that also 
influences immunologic and inflammatory systems in the body25.  
Intervention studies aiming at improving subjective emotional wellbeing and resilience 
among adolescents have been performed in clinical settings as well as in community and 
school settings. Results indicate that programs aimed at building resilience may be effective, 
but study quality seems unsatisfactory26. Also, low-cost web-based interventions, mostly 
applying cognitive behavior therapy in clinical and high-risk young populations, are 
promising27. Several reviews maintain that school-based programs targeting social-emotional 
learning, bullying prevention and stress management are effective also in low-income 
countries28, 29. Others, e.g. of the Pennsylvania Resilience Program, find beneficial effects 
even 12 months after the termination of the program, but the researchers responsible for the 
program maintain that long term studies are needed in order to judge if such programs are 
effective and cost-effective30. Effective school programs for the promotion of positive body 
attitude have been performed, but also in this field we lack evidence of long-term effect31. 
Strengths and weaknesses 
The Young-HUNT-survey had a high participation rate (90%), and the participants filled in 
the questionnaire in a complete manner. The internal consistency of the SW questions were 
satisfactory, and other studies also revealed high internal reliability15. Confidentiality was 
safeguarded and it is reasonable, therefore, to maintain that participants answered the 
questions in an honest manner. 
Recall bias, negative affectivity and other methodological shortcomings are threats to the 
validity of self-administered surveys3. However, we used dispensed drugs from a national 
register, and it is reasonable to maintain that this is a more reliable and objective health-
outcome measure than self-reports. We used a short version of a reliable and valid subjective 
wellbeing scale, where two questions pertained to the cognitive- and two questions to the 
affective dimension of SW. The reliability was satisfactory, and the results from the present 
study prove that this short form perform with specific and predictive validity. 
Regrettably, we could not adjust for socioeconomic status (SES) at inclusion or at follow-up. 
Earlier research has confirmed a social gradient in drug use, also among adolescents and 
young adults16. The research on the associations between SES and SW and between SES and 
body concern are conflicting8, 15, and shows that SES in younger age explains very little of the 
variation in SW17. However, there is a strong association between SW and body concern10. 
Predictive models presented in this study, where we adjusted for the inter-relationship 
between these predictors are, therefore, recommendable. In stratified analyses we ruled out 
significant interactions between sex and the predictors.  
We performed ordinal regression analyses as predictive models for the associations between 
predictors and outcomes, since the outcomes were skewed. We are aware that other statistical 
methods, as for instance negative binominal regression models, would have preserved more of 
the information from the outcomes. On the other hand, we may maintain that ordinal logistic 
regression gives a conservative estimate of the associations in the study, safeguarding 
protection against type I errors. 
We used dieting and dieting desire as expressions for body dissatisfaction. This is a somewhat 
unspecific measure for such dissatisfaction. Some of the adolescents may have experienced 
other forms of body dissatisfaction, such as muscle dysmorphia18, most common amongst 
boys and men, where one sees one's own body as being too small or skinny or not muscular 
enough. This form of body dissatisfaction will not have been captured in our study. Still, we 
confirmed that BMI was similar among adolescents with dieting (and -desire) as among 
adolescents reporting satisfaction with their body and weight (analyses not shown). Therefore, 
we maintain that dieting and –desire express a concern with the body. 
 
Conclusion 
Our study confirms that SW and body concern are important health determinants in the 
transition between adolescence and adulthood. We need to learn more about how we can 
promote wellbeing and self-acceptance, but this knowledge is important for public health, for 
school management, politicians and the public as a whole in our efforts to promote wellbeing, 
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Table 1. Predictors used in the study of medication use 17 to 18 years later. 
Variable Questions Response alternatives 
Number of valid 
responses % valid responses 
Lack of SW 
(n=8771*) 
When you think about your life at present. would you 
say that you are mostly satisfied with your life, or 
mostly dissatisfied?  
Scale from 1-7, 7 most 
dissatisfied 8875  
 
Do you mostly feel strong and fit, or tired and worn 
out?    Scale from 1-7, 7 most worn out 8883  
 Are you usually happy or dejected?  Scale from 1-7, 7 most dejected 8881  
 
Over the last month, have you suffered from 
nervousness (felt irritable, anxious, tense, or restless)? Scale from 1-4, 4: frequently# 8829  
Body concern 
(n= 8737) Are you trying to lose weight? No, my weight is ok 6188 70.8 
  
No, but I need to lose weight 1608 18.4 
  
Yes 941 10.8 
*Number of persons for which a sum score was calculated. The sum-variable was excluded from analysis if the participants had answered less than two of the 
questions. 
#Rescaled to a 1-7 scale for analysis. 
  
Table 2. Groups of medication investigated, number of users and number of prescriptions collected during 2013 and 2014.  
ATC-group 
 Number of collected 
prescriptions per person Number of users (%) Mean (SD) 
All  
(excluding contraceptives 
(G02B and G03A)) 
All prescriptions 0-1  
2 - 6  
7 - 587  
3116 (34.7)  








2 - 30 
5411 (60.2)  
1876 (20.9)  
1695 (18.9)  
0.86 (1.74) 
M 




2 - 62 
6266 (69.8)  
1399 (15.6)  
1317 (14.6)  
0.71 (1.88) 
N05B.  
N05C (A-F)  




2 - 94 
8380 (93.3)  
300 (3.3)  
302 (3.4)  
0.35 (3.13) 
N05A  





1 - 4 
5 - 212 
8170 (91.0)  
384 (4.2)  




Table 3. Ordinal logistic regression showing the effects (odds ratio (OR) and confidence interval (CI)) of sex, age, medication use at 
inclusion, lack of subjective wellbeing (SW) and body concern on the total use of medication 17 to 18 years later. 
  Bivariate analysis Full model analysis  
  
OR (95 % CI) p-value OR (95 % CI) p-value  









1.01 (0.98-1.03) 0.634 0.99 (0.97-1.01) 0.261 
 
Medication use at 
inclusion 
 
1.40 (1.35-1.46) <0.001 1.31 (1.26-1.36) <0.001 
 
Lack of SW 
 
1.12 (1.07-1.17) <0.001* 1.11 (1.06-1.16) <0.001 
 
Are you trying to lose 





No, but I should lose 
weight 1.18 (1.06-1.30) 0.002* 1.14 (1.02-1.26) 0.016 
 
 
Yes 1.32 (1.16-1.51) <0.001* 1.27 (1.11-1.45) 0.001 
 
 Explained varience 
(Nagelkerke)           0.079 
 
Table 4. Ordinal logistic regression showing the effects (odds ratio (OR) and confidence interval (CI)) of sex, age, medication use at inclusion, lack of 
subjective wellbeing and body concern on the use of medication for infections and the musculo-skelatal system 17 to 18 years later. 
    Antiinfectives for systemic use   Medication for the musculo-skeletal system   
  Bivariate analysis Full model analysis  Bivariate analysis Full model analysis  
  
OR (95 % CI) 
p-
value 
OR (95 % CI) 
p-
value  
OR (95 % CI) p-value OR (95 % CI) p-value 
  









Female 2.30 (2.11-2.50) <0.001 2.12 (1.94-2.32) <0.001 
 




0.98 (0.96-1.00) 0.045 0.96 (0.94-0.99) 0.003 
 






1.21 (1.16-1.25) 0.001 1.13 (1.09-1.18) <0.001 
 
1.18 (1.13-1.23) <0.001 1.15 (1.11-1.20) <0.001 
 
Lack of SW 
 
1.05 (1.01-1.11) 0.033* 1.04 (0.99-1.10) 0.093 
 
1.04 (0.99-1.10) 0.098* 1.03 (0.97-1.08) 0.34 
 
Are you 
trying to lose 
weight? 
No, my 









No, but I 
should lose 
weight 1.02 (0.91-1.14) 0.77* 1.00 (0.90-1.12) 0.967 
 
1.20 (1.06-1.35) 0.003* 1.19 (1.05-1.34) 0.002 
 
 
Yes 1.25 (1.09-1.43) 0.001* 1.23 (1.07-1.41) 0.004 
 




(Nagelkerke)           0.058         0.014 
*Adjusted for sex, age and medication use at inclusion 
Table 5. Ordinal logistic regression showing the effects (odds ratio (OR) and confidence interval (CI)) of sex, age, medication use at inclusion, lack of subjective 
wellbeing (SW) and body concern on the use of anxiolytics, hypnotics and sedatives, and  antipsychotics, antidepressants and psychostimulants, 17 to 18 years 
later. 
  
 Anxiolytics, hypnotics and sedatives  
 
Antipsychotics, antidepressants and psychostimulants 
 
  Bivariate analysis Full model analysis  Bivariate analysis Full model analysis  
  
OR (95 % CI) p-value OR (95 % CI) p-value  OR (95 % CI) p-value OR (95 % CI) p-value 
 









Female 1.88 (1.58-2.23) <0.001 1.58 (1.32-1.90) <0.001 
 




1.01 (0.96-1.06) 0.73 0.98 (0.93-1.03) 0.362 
 






1.21 (1.13-1.29) <0.001 1.13 (1.05-1.21) <0.001 
 
1.19 (1.13-1.26) <0.001 1.12 (1.05-1.19) <0.001 
 
Lack of SW 
 
1.37 (1.25-1.50) <0.001* 1.34 (1.22-1.47) <0.001 
 
1.49 (1.38-1.61) <0.001* 1.47 (1.35-1.60) <0.001 
 
Are you 
trying to lose 
weight? 
No, my 









No, but I 
should lose 
weight 1.25 (1.01-1.55) 0.038* 1.15 (0.93-1.42) 0.208 
 
1.33 (1.10-1.60) 0.011* 1.19 (0.98-1.43) 0.08 
 
 
Yes 1.37 (1.07-1.76) 0.014* 1.21 (0.94-1.56) 0.141 
 





     
0.030 
    
0.037 
*Adjusted for sex, age and medication use at inclusion 
 
 
